Atrophy: Clinical Trials

33 trials for Atrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed, 6 unknown, 3 recruiting, 2 active not recruiting. 33 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 433Completed 17, Unknown 6, Recruiting 3, Active not recruiting 2, Not yet recruiting 2, Terminated 2, Withdrawn 1

Follow Atrophy: new trials by email Literature Review of Atrophy trials Research Report on Atrophy

Trials (filtered) newest first · largest first

All 33 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment Evaluates Whether a 12-week Exercise and Individualized Nutrition Program Can Reduce Muscle and Bone Loss and Improve Strength, Fitness, and Function in Obese Adults on GLP-1
Semaglutide, Dietary Counseling, Exercise - GLP - 1, Obesity & Overweight
Phase 4Not yet recruitingWilliam Marsh Rice University202026-04-062026-04-28
Restoring Facial Volume After GLP-1 Weight Loss With Radiesse
Hyperdiluted Calcium Hydroxylapatite, Calcium hydroxylapatite, Calcium hydroxylapatite with integral lidocaine - Volume Loss (Soft Tissue Ptosis or Atrophy )
Phase 4RecruitingKalpna Kay Durairaj, MD, FACS482026-02-012026-09-09
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients
Roxadustat, Recombinant human erythropoietin (EPO) - Sarcopenia, Anemia Associated With Chronic Kidney Disease (CKD)
Phase 4Not yet recruitingTianjin Medical University General Hospital602025-09-102025-09-09
GLP-1s to Enhance Lasting Optimal Weight
Tirzepatide - Obesity
Phase 4Active not recruitingWake Forest University Health Sciences402025-07-072026-10-02
Branched Chain Amino Acids for Sarcopenia in Patients Undergoing Total Knee Arthroplasty
Livact Granule - Sarcopenia, Total Knee Arthroplasty
Phase 4RecruitingSeoul National University Hospital1402025-02-062026-06-09
Clinical Intervention of Idecalcitol Combined With Whey Protein Powder and Exercise for Sarcopenia
exercise, whey protein powder, Eldecalcitol - Sarcopenia
Phase 4RecruitingZhejiang Provincial People's Hospital4502024-06-162024-08-05
Effect of Alfacalcidol on Muscle Function in Osteoporosis Patients
alfacalcidol, placebo, Denosumab - Sarcopenia
Phase 4UnknownYonsei University3402024-02-132024-02-22
Muscle Impact of Treating Osteoporosis
Denosumab, Zoledronic Acid, Denosumab Placebo - Sarcopenia, Osteoporosis
Phase 4CompletedNami Safai Haeri202023-02-142026-10-27
Bioindicators Associated With Sarcopenia Before and After Intensive Lifestyle Intervention
3-month intensive intervention - Sarcopenia
Phase 4CompletedLijun Yang992022-03-012023-11-13
Safety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA) (OFELIA)
OAV101 - Muscular Atrophy, Spinal
Phase 4CompletedNovartis Pharmaceuticals162021-11-042024-10-09
Identification of Sarcopenia in Knee Osteoarthritis With Ultrasonography and Evaluation of Muscle Architecture Change by Ultrasonography After Isokinetic Exercise Program
Knee strengthening exercises with isokinetic dynamometer, Strengthening around the knees with home exercise programe - Osteoarthritis of the Knee, Sarcopenia
Phase 4UnknownSema Dağcı602021-08-182021-08-25
Testosterone in Bariatric Patients
Testosterone Undecanoate - Bariatric Surgery Candidate, Male Hypogonadism
Phase 4CompletedEsbjerg Hospital - University Hospital of Southern Denmark642020-12-172026-09-11
The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients
Olimel N12, Glucose IV - End Stage Renal Disease, Malnutrition
Phase 4Active not recruitingErasmus Medical Center1662019-09-162026-02-12
Role of AST120 for Sarcopenia Prevention in Pre-dialysis Chronic Kidney Disease
Renamezin - Chronic Kidney Diseases
Phase 4CompletedGumi Cha Medical Center1502018-11-232020-12-17
Mediterranean Diet, Circuit Resistance Training, Empagliflozin in Elderly With Type 2 Diabetes: a Study Protocol
Circuit resistance training (CRT), Vegeterranean diet (V-Med diet), Empagliflozin 10 MG - Diabetes Mellitus, Type 2, Sarcopenia
Phase 4CompletedTel-Aviv Sourasky Medical Center1002018-05-092025-09-04
The Impact of N-Acetylcysteine on Volumetric Retention of Autologous Fat Graft for Breast Asymmetry Correction
N-Acetylcysteine (NAC) - Breast; Deformity, Congenital, Graft Loss
Phase 4UnknownCentre of Postgraduate Medical Education152017-07-042017-07-06
Effects of Supplementation of Vitamin D in Patients With Crohn's Disease
Vitamin D, Placebo - Crohn Disease, Vitamin D Deficiency
Phase 4UnknownFederal University of Juiz de Fora1102016-12-012018-06-29
LPD+α-ketoacids on Autophagy and Improving Muscle Wasting in CKD
keto-amino acids - Muscular Atrophy
Phase 4UnknownYUAN Wei-jie602016-11-012016-11-01
The Effects of Long Term Cyclic Testosterone Administration on Muscle Function and Bone in Older Men
Testosterone enanthate, Placebo - Sarcopenia
Phase 4WithdrawnThe University of Texas Medical Branch, Galveston2016-01-012015-10-02
Body Composition Measurements in Chronic Heart Failure
bioelectrical impedance analysis (Bodystat, Quadscan 4000), dual-energy X-ray absorptiometry (Hologic, Delphi QDR), hand grip strength - Cachexia, Sarcopenia
Phase 4UnknownHungarian Institute of Cardiology352016-01-012016-02-22

Showing 20 of 33. Sign in to see all of them.

Narrower conditions

Sarcopenia (20)  ·  Muscular Atrophy (9)  ·  Muscular Diseases (3)  ·  Obesity (3)  ·  Weight Loss (3)  ·  Frailty (2)  ·  Muscle Weakness (2)  ·  Anemia (1)  ·  Bone Diseases, Metabolic (1)  ·  Brain Injuries (1)  ·  Bulbo-Spinal Atrophy, X-Linked (1)  ·  Cachexia (1)  ·  Congenital Abnormalities (1)  ·  Critical Illness (1)

Broader conditions

Pathological Conditions, Anatomical (33)  ·  Pathological Conditions, Signs and Symptoms (33)  ·  Nervous System Diseases (29)  ·  Neurologic Manifestations (29)  ·  Neuromuscular Manifestations (29)  ·  Signs and Symptoms (29)  ·  Muscular Atrophy (20)  ·  Musculoskeletal Diseases (8)  ·  Nutritional and Metabolic Diseases (8)  ·  Pathologic Processes (8)  ·  Body Weight (6)  ·  Nutrition Disorders (6)  ·  Body Weight Changes (4)  ·  Disease Attributes (4)

Interventions

Exercise (3)  ·  Testosterone (3)  ·  Denosumab (2)  ·  Vitamin D (2)  ·  testosterone enanthate (2)  ·  1-((2-hydroxyethyl)amino)-2-amino-1,2-dideoxyglucose triphenyltin(IV) (1)  ·  Absorptiometry, Photon (1)  ·  Acetylcysteine (1)  ·  Allopurinol (1)  ·  Amino Acids (1)  ·  Botulinum Toxins, Type A (1)  ·  Filgrastim (1)  ·  Gels (1)  ·  Hand Strength (1)  ·  Lactose (1)

Sponsors

Novartis Pharmaceuticals (2)  ·  The University of Texas Medical Branch, Galveston (2)  ·  Wake Forest University Health Sciences (2)  ·  Beer, Kenneth R., M.D., PA (1)  ·  Boston Medical Center (1)  ·  Centre of Postgraduate Medical Education (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Erasmus Medical Center (1)  ·  Esbjerg Hospital - University Hospital of Southern Denmark (1)  ·  Federal University of Juiz de Fora (1)  ·  Georgetown University (1)  ·  Gumi Cha Medical Center (1)  ·  Hospital Clinic of Barcelona (1)  ·  Hungarian Institute of Cardiology (1)  ·  Insel Gruppe AG, University Hospital Bern (1)

Countries

United States (11)  ·  South Korea (3)  ·  Argentina (2)  ·  Brazil (2)  ·  China (2)  ·  Denmark (2)  ·  Netherlands (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Hungary (1)  ·  Israel (1)  ·  Poland (1)  ·  Switzerland (1)  ·  Turkey (Türkiye) (1)

Top investigators

Allan Struthers, MD FRCP (1)  ·  Anders Perner, Professor, MD, PhD (1)  ·  Carlos Simon, MD, PhD (1)  ·  Clare Clarke, PhD MCSP (1)  ·  Denise Houston, PhD (1)  ·  Dennis Sullivan, MD (1)  ·  Dr Martin Connolly, MD, FRCP (1)  ·  Du Hyun Ro, MD, PhD (1)  ·  Ewout J Hoorn, MD PhD (1)  ·  Fernando Pagan, MD (1)  ·  Graeme Houston, FRCP FRCR (1)  ·  Jacob George, MRCP MD (1)  ·  Jianfang Ni, bachelor (1)  ·  Joan Trabal, RD, MS (1)

Results publications

PMID 16260965, PMID 18996225, PMID 20592293, PMID 21084399, PMID 21697501, PMID 23292288, PMID 26384164, PMID 27005892, PMID 27585532, PMID 28936712, PMID 28950424, PMID 28981994, PMID 29035179, PMID 29846604, PMID 29898702, PMID 31438863, PMID 32221675, PMID 32424535, PMID 34862753, PMID 35086483, PMID 35806119, PMID 35963741, PMID 36186800, PMID 36287929, PMID 36364144, PMID 36721961, PMID 37812446, PMID 38224135, PMID 38333911, PMID 39227842, PMID 41789181

NIH funding

2018 (2), 2023 (1), P30AG021332 (1), P30AG024827 (1), U01AG014369 (1)